{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:34:12Z","timestamp":1788474852850,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00059-023-05172-8","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T18:03:07Z","timestamp":1682445787000},"page":"280-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronic thromboembolic pulmonary hypertension\u2014medical, interventional, and surgical therapy","Chronische thromboembolische pulmonale Hypertonie\u00a0\u2013 medikament\u00f6se, interventionelle und chirurgische Behandlung"],"prefix":"10.1007","volume":"48","author":[{"given":"Christoph B.","family":"Wiedenroth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethard","family":"Pruefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam S. D.","family":"Adameit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"5172_CR1","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"25","author":"M Humbert","year":"2022","unstructured":"Humbert\u00a0M, Kovacs\u00a0G, Hoeper\u00a0MM et\u00a0al (2022) 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir\u00a0J 25:2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022","journal-title":"Eur Respir J"},{"key":"5172_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1160\/TH13-07-0538","volume":"112","author":"L Guerin","year":"2014","unstructured":"Guerin\u00a0L, Couturaud\u00a0F, Parent\u00a0F et\u00a0al (2014) Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 112:598\u2013605. https:\/\/doi.org\/10.1160\/TH13-07-0538","journal-title":"Thromb Haemost"},{"issue":"22","key":"5172_CR3","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa032274","volume":"350","author":"V Pengo","year":"2004","unstructured":"Pengo\u00a0V, Lensing\u00a0AWA, Prins\u00a0MH et\u00a0al (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N\u00a0Engl J Med 350(22):2257\u20132264. https:\/\/doi.org\/10.1056\/NEJMoa032274","journal-title":"N Engl J Med"},{"issue":"6","key":"5172_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3324\/haematol.2009.018960","volume":"95","author":"FA Klok","year":"2010","unstructured":"Klok\u00a0FA, van Kralingen\u00a0KW, van Dijk\u00a0APJ et\u00a0al (2010) Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 95(6):970\u2013975. https:\/\/doi.org\/10.3324\/haematol.2009.018960","journal-title":"Haematologica"},{"issue":"2","key":"5172_CR5","doi-asserted-by":"publisher","first-page":"1601792","DOI":"10.1183\/13993003.01792-2016","volume":"49","author":"YM Ende-Verhaar","year":"2017","unstructured":"Ende-Verhaar\u00a0YM, Cannegieter\u00a0SC, Vonk Noordegraaf\u00a0A et al (2017) Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a\u00a0contemporary view of the published literature. Eur Respir\u00a0J 49(2):1601792. https:\/\/doi.org\/10.1183\/13993003.01792-2016","journal-title":"Eur Respir J"},{"issue":"4","key":"5172_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1160\/TH16-10-0790","volume":"117","author":"ML Bochenek","year":"2017","unstructured":"Bochenek\u00a0ML, Rosinus\u00a0NS, Lankeit\u00a0M et\u00a0al (2017) From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension. Thromb Haemost 117(4):769\u2013783. https:\/\/doi.org\/10.1160\/TH16-10-0790","journal-title":"Thromb Haemost"},{"key":"5172_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jth.13175","volume":"14","author":"FA Klok","year":"2016","unstructured":"Klok\u00a0FA, Dzikowska-Diduch\u00a0O, Kostrubiec\u00a0M et al (2016) Derivation of a\u00a0clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J\u00a0Thromb Haemost 14:121\u2013128. https:\/\/doi.org\/10.1111\/jth.13175","journal-title":"J Thromb Haemost"},{"issue":"2","key":"5172_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.00049312","volume":"41","author":"IM Lang","year":"2013","unstructured":"Lang\u00a0IM, Pesavento\u00a0R, Bonderman\u00a0D, Yuan\u00a0JX (2013) Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a\u00a0current understanding. Eur Respir\u00a0J 41(2):462\u2013468. https:\/\/doi.org\/10.1183\/09031936.00049312","journal-title":"Eur Respir J"},{"key":"5172_CR9","doi-asserted-by":"publisher","first-page":"204589401988262","DOI":"10.1177\/2045894019882620","volume":"10","author":"S Narechania","year":"2020","unstructured":"Narechania\u00a0S, Renapurkar\u00a0R, Heresi\u00a0GA (2020) Mimickers of chronic thromboembolic pulmonary hypertension on imaging tests: a\u00a0review. Pulm Circ 10:2045894019882620. https:\/\/doi.org\/10.1177\/2045894019882620","journal-title":"Pulm Circ"},{"issue":"2","key":"5172_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1378\/chest.81.2.151","volume":"81","author":"M Riedel","year":"1982","unstructured":"Riedel\u00a0M, Stanek\u00a0V, Widimsky\u00a0J, Prerovsky\u00a0I (1982) Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81(2):151\u2013158","journal-title":"Chest"},{"issue":"3","key":"5172_CR11","doi-asserted-by":"publisher","first-page":"1901647","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"SV Konstantinides","year":"2019","unstructured":"Konstantinides\u00a0SV, Meyer\u00a0G, Becattini\u00a0C et\u00a0al (2019) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European society of cardiology (ESC). Eur Respir\u00a0J 54(3):1901647. https:\/\/doi.org\/10.1183\/13993003.01647-2019","journal-title":"Eur Respir J"},{"key":"5172_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fcvm.2020.00051","volume":"7","author":"F Lasch","year":"2020","unstructured":"Lasch\u00a0F, Karch\u00a0A, Koch\u00a0A et al (2020) Comparison of MRI and VQ-SPECT as a\u00a0screening test for patients with suspected CTEPH: CHANGE-MRI study design and rationale. Front Cardiovasc Med 7:51. https:\/\/doi.org\/10.3389\/fcvm.2020.00051","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"5172_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.healun.2021.07.020","volume":"40","author":"M de Perrot","year":"2021","unstructured":"de Perrot\u00a0M, Gopalan\u00a0D, Jenkins\u00a0D et\u00a0al (2021) Evaluation and management of patients with chronic thromboembolic pulmonary hypertension \u2013 consensus statement from the ISHLT. J\u00a0Heart Lung Transplant 40(11):1301\u20131326. https:\/\/doi.org\/10.1016\/j.healun.2021.07.020","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"5172_CR14","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1007\/s00330-016-4280-z","volume":"26","author":"JB Hinrichs","year":"2016","unstructured":"Hinrichs\u00a0JB, Renne\u00a0J, Hoeper\u00a0MM, Olsson\u00a0KM, Wacker\u00a0FK, Meyer\u00a0BC (2016) Balloon pulmonary angioplasty: applicability of C\u2011Arm CT for procedure guidance. Eur Radiol 26(11):4064\u20134071. https:\/\/doi.org\/10.1007\/s00330-016-4280-z","journal-title":"Eur Radiol"},{"key":"5172_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.healun.2022.02.002","volume":"41","author":"MS Humbert","year":"2022","unstructured":"Humbert\u00a0MS, Simonneau\u00a0G, Pittrow\u00a0D et\u00a0al (2022) Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J\u00a0Heart Lung Transplant 41:716\u2013721. https:\/\/doi.org\/10.1016\/j.healun.2022.02.002","journal-title":"J Heart Lung Transplant"},{"key":"5172_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","volume":"132","author":"V Pengo","year":"2018","unstructured":"Pengo\u00a0V, Denas\u00a0G, Zoppellaro\u00a0G et al (2018) Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 132:1365\u20131371. https:\/\/doi.org\/10.1182\/blood-2018-04-848333","journal-title":"Blood"},{"key":"5172_CR17","doi-asserted-by":"publisher","first-page":"e41603","DOI":"10.1371\/journal.pone.0041603","volume":"7","author":"C Nagel","year":"2012","unstructured":"Nagel\u00a0C, Prange\u00a0F, Guth\u00a0S et\u00a0al (2012) Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS One 7:e41603. https:\/\/doi.org\/10.1371\/journal.pone.0041603","journal-title":"PLoS One"},{"key":"5172_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1159\/000508754","volume":"99","author":"C Nagel","year":"2020","unstructured":"Nagel\u00a0C, Nasereddin\u00a0M, Benjamin\u00a0N et al (2020) Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension as early follow-up treatment after pulmonary endarterectomy: a\u00a0prospective cohort study. Respiration 99:577\u2013588. https:\/\/doi.org\/10.1159\/000508754","journal-title":"Respiration"},{"key":"5172_CR19","doi-asserted-by":"publisher","first-page":"1801915","DOI":"10.1183\/13993003.01915-2018","volume":"53","author":"NH Kim","year":"2019","unstructured":"Kim\u00a0NH, Delcroix\u00a0M, Jais\u00a0X et\u00a0al (2019) Chronic thromboembolic pulmonary hypertension. Eur Respir\u00a0J 53:1801915. https:\/\/doi.org\/10.1183\/13993003.01915-2018","journal-title":"Eur Respir J"},{"key":"5172_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.06.011","author":"M Lankeit","year":"2017","unstructured":"Lankeit\u00a0M, Krieg\u00a0V, Hobohm\u00a0L et\u00a0al (2017) Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J\u00a0Heart Lung Transplant. https:\/\/doi.org\/10.1016\/j.healun.2017.06.011","journal-title":"J Heart Lung Transplant"},{"key":"5172_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","volume":"133","author":"M Delcroix","year":"2016","unstructured":"Delcroix\u00a0M, Lang\u00a0I, Pepke-Zaba\u00a0J et al (2016) Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 133:859\u2013871. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016522","journal-title":"Circulation"},{"key":"5172_CR22","doi-asserted-by":"publisher","first-page":"1800589","DOI":"10.1183\/13993003.00589-2018","volume":"52","author":"SR Quadery","year":"2018","unstructured":"Quadery\u00a0SR, Swift\u00a0AJ, Billings\u00a0CG et\u00a0al (2018) The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir\u00a0J 52:1800589. https:\/\/doi.org\/10.1183\/13993003.00589-2018","journal-title":"Eur Respir J"},{"key":"5172_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1209657","volume":"369","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani\u00a0HA, D\u2019Armini\u00a0AM, Grimminger\u00a0F et\u00a0al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N\u00a0Engl J Med 369:319\u2013329. https:\/\/doi.org\/10.1056\/NEJMoa1209657","journal-title":"N Engl J Med"},{"key":"5172_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S2213-2600(18)30367-9","volume":"7","author":"R Sadushi-Kolici","year":"2019","unstructured":"Sadushi-Kolici\u00a0R, Jansa\u00a0P, Kopec\u00a0G et al (2019) Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a\u00a0double-blind, phase 3, randomised controlled trial. Lancet Respir Med 7:239\u2013248. https:\/\/doi.org\/10.1016\/S2213-2600(18)30367-9","journal-title":"Lancet Respir Med"},{"key":"5172_CR25","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00850-2020","author":"S Guth","year":"2021","unstructured":"Guth\u00a0S, D\u2019Armini\u00a0AM, Delcroix\u00a0M et\u00a0al (2021) Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH registry. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00850-2020","journal-title":"ERJ Open Res"},{"key":"5172_CR26","doi-asserted-by":"publisher","first-page":"1802095","DOI":"10.1183\/13993003.02095-2018","volume":"53","author":"P Brenot","year":"2019","unstructured":"Brenot\u00a0P, Jais\u00a0X, Taniguchi\u00a0Y et\u00a0al (2019) French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir\u00a0J 53:1802095. https:\/\/doi.org\/10.1183\/13993003.02095-2018","journal-title":"Eur Respir J"},{"key":"5172_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/CIRCINTERVENTIONS.112.971390","volume":"5","author":"M Kataoka","year":"2012","unstructured":"Kataoka\u00a0M, Inami\u00a0T, Hayashida\u00a0K et\u00a0al (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756\u2013762. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.112.971390","journal-title":"Circ Cardiovasc Interv"},{"key":"5172_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.iccl.2017.09.003","volume":"7","author":"E Mahmud","year":"2018","unstructured":"Mahmud\u00a0E, Behnamfar\u00a0O, Ang\u00a0L et\u00a0al (2018) Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Interv Cardiol Clin 7:103\u2013117. https:\/\/doi.org\/10.1016\/j.iccl.2017.09.003","journal-title":"Interv Cardiol Clin"},{"key":"5172_CR29","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","volume":"5","author":"H Mizoguchi","year":"2012","unstructured":"Mizoguchi\u00a0H, Ogawa\u00a0A, Munemasa\u00a0M et\u00a0al (2012) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:748\u2013755. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.112.971077","journal-title":"Circ Cardiovasc Interv"},{"key":"5172_CR30","doi-asserted-by":"publisher","first-page":"1602409","DOI":"10.1183\/13993003.02409-2016","volume":"49","author":"KM Olsson","year":"2017","unstructured":"Olsson\u00a0KM, Wiedenroth\u00a0CB, Kamp\u00a0JC et\u00a0al (2017) Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir\u00a0J 49:1602409. https:\/\/doi.org\/10.1183\/13993003.02409-2016","journal-title":"Eur Respir J"},{"key":"5172_CR31","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/CIRCULATIONAHA.116.024201","volume":"134","author":"T Inami","year":"2016","unstructured":"Inami\u00a0T, Kataoka\u00a0M, Yanagisawa\u00a0R et al (2016) Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Circulation 134:2030\u20132032. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024201","journal-title":"Circulation"},{"issue":"8","key":"5172_CR32","doi-asserted-by":"publisher","first-page":"e010243","DOI":"10.1161\/CIRCINTERVENTIONS.120.010243","volume":"14","author":"C Gerges","year":"2021","unstructured":"Gerges\u00a0C, Friewald\u00a0R, Gerges\u00a0M et\u00a0al (2021) Efficacy and safety of percutaneous pulmonary artery subtotal occlusion and chronic total occlusion intervention in chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 14(8):e10243. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.010243","journal-title":"Circ Cardiovasc Interv"},{"key":"5172_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.004029","author":"A Ogawa","year":"2017","unstructured":"Ogawa\u00a0A, Satoh\u00a0T, Fukuda\u00a0T et\u00a0al (2017) Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a\u00a0multicenter registry. Circ Cardiovasc Qual Outcomes. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.117.004029","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"5172_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051038","author":"S Darocha","year":"2021","unstructured":"Darocha\u00a0S, Araszkiewicz\u00a0A, Kurzyna\u00a0M et\u00a0al (2021) Balloon pulmonary angioplasty in technically operable and technically inoperable chronic thromboembolic pulmonary hypertension. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm10051038","journal-title":"J Clin Med"},{"key":"5172_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.08.011","author":"CB Wiedenroth","year":"2022","unstructured":"Wiedenroth\u00a0CB, Rolf\u00a0A, Steinhaus\u00a0K et\u00a0al (2022) Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension. J\u00a0Heart Lung Transplant. https:\/\/doi.org\/10.1016\/j.healun.2022.08.011","journal-title":"J Heart Lung Transplant"},{"key":"5172_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00214-4","author":"X Ja\u00efs","year":"2022","unstructured":"Ja\u00efs\u00a0X, Brenot\u00a0P, Bouvaist\u00a0H et al (2022) Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a\u00a0multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(22)00214-4","journal-title":"Lancet Respir Med"},{"key":"5172_CR37","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.115.019470","volume":"133","author":"JE Cannon","year":"2016","unstructured":"Cannon\u00a0JE, Su\u00a0L, Kiely\u00a0DG et al (2016) Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the UK national cohort. Circulation 133:1761\u20131771. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019470","journal-title":"Circulation"},{"key":"5172_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.healun.2015.10.030","volume":"35","author":"CB Wiedenroth","year":"2016","unstructured":"Wiedenroth\u00a0CB, Liebetrau\u00a0C, Breithecker\u00a0A et\u00a0al (2016) Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J\u00a0Heart Lung Transplant 35:591\u2013596. https:\/\/doi.org\/10.1016\/j.healun.2015.10.030","journal-title":"J Heart Lung Transplant"},{"key":"5172_CR39","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","volume":"141","author":"E Mayer","year":"2011","unstructured":"Mayer\u00a0E, Jenkins\u00a0D, Lindner\u00a0J et\u00a0al (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J\u00a0Thorac Cardiovasc Surg 141:702\u2013710. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.11.024","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-023-05172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-023-05172-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-023-05172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:08:30Z","timestamp":1690819710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-023-05172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5172"],"URL":"https:\/\/doi.org\/10.1007\/s00059-023-05172-8","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"2 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The second sentence in the abstract should have read \u2018Currently, three specific treatmentmodalities are available: pulmonary endarterectomy, balloon pulmonary angioplasty, and targeted medical therapy.\u2019 instead of \u2018Currently, three specific treatmentmodalities are available: pulmonary endarterectomy, pulmonary balloon angioplasty, and targeted medical therapy.\u2019","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.B.\u00a0Wiedenroth has received speaker fees and\/or consultant honoraria from Actelion, AOP Orphan Pharmaceuticals AG, Bayer AG, BTG, MSD, OrphaCare GmbH, and Pfizer. D.\u00a0Pruefer has received speaker fees and\/or consultant honoraria from AstraZeneca, Johnson&Johnson, and Bayer AG. E.\u00a0Mayer has received speaker fees and\/or consultant honoraria from Actelion, Janssen, Bayer AG, and MSD. S.\u00a0Guth has received speaker fees and\/or consultant honoraria from Actelion, Bayer AG, MSD, and Pfizer. M.S.\u00a0D.\u00a0Adameit declares that she has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}